Impact of Glucose-Lowering Agents on the Risk of Cancer in Type 2 Diabetic Patients. The Barcelona Case-Control Study

BACKGROUND: The aim of the present study is to evaluate the impact of glucose-lowering agents in the risk of cancer in a large type 2 diabetic population. METHODS: A nested case-control study was conducted within a defined cohort (275,164 type 2 diabetic patients attending 16 Primary Health Care Cen...

Descripción completa

Detalles Bibliográficos
Autores principales: Simó, Rafael, Plana-Ripoll, Oleguer, Puente, Diana, Morros, Rosa, Mundet, Xavier, Vilca, Luz M., Hernández, Cristina, Fuentes, Inmaculada, Procupet, Adriana, Tabernero, Josep M., Violán, Concepción
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3836986/
https://www.ncbi.nlm.nih.gov/pubmed/24278227
http://dx.doi.org/10.1371/journal.pone.0079968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3836986/
https://www.ncbi.nlm.nih.gov/pubmed/24278227
http://dx.doi.org/10.1371/journal.pone.0079968

Ejemplares similares